Fingerprint
Dive into the research topics of 'A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours
U Lassen, D L Nielsen, M Sørensen, L Winstedt, T Niskanen, Y Stenberg, S Pakola, J-M Stassen, S Glazer